Cubist Systematic Strategies’s Genesis Healthcare, Inc. GEN Stock Holding History

Cubist Systematic Strategies’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,102	Closed	-$14K	–	2370
2018 Q3	$14K	Buy	10,102 +3,002	+42%	+$4.75K	﹤0.01%	1809
2018 Q2	$16K	Sell	7,100 -10,137	-59%	-$19.6K	﹤0.01%	1712
2018 Q1	$26K	Hold	17,237	–	–	﹤0.01%	1741
2017 Q4	$13K	Hold	17,237	–	–	﹤0.01%	1848
2017 Q3	$20K	Hold	17,237	–	–	﹤0.01%	1777
2017 Q2	$30K	Sell	17,237 -3,020	-15%	-$6.42K	﹤0.01%	1589
2017 Q1	$53K	Buy	20,257 +6,300	+45%	+$22.6K	﹤0.01%	1468
2016 Q4	$59K	Hold	13,957	–	–	﹤0.01%	1564
2016 Q3	$37K	Hold	13,957	–	–	﹤0.01%	1591
2016 Q2	$25K	Hold	13,957	–	–	﹤0.01%	1631
2016 Q1	$32K	Buy	+13,957	New	+$31.6K	﹤0.01%	1505
2015 Q2	–	Sell	-41,326	Closed	-$294K	–	2144
2015 Q1	$294K	Buy	+41,326	New	+$312K	0.01%	1272

Other funds holding GEN

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CPA

Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GWS

Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

Cubist Systematic Strategies's GEN Position: Q4 2018 in Review

Cubist Systematic Strategies sold out of Genesis Healthcare, Inc. (GEN) in Q4 2018, closing a stake of 10,102 shares — an estimated $14K sold.

Cubist Systematic Strategies first reported a position in GEN in Q1 2015 and held it in 12 quarters. The position peaked at $294K in Q1 2015. 75 funds tracked by Wall St. Rank hold GEN as of Q4 2018.

Cubist Systematic Strategies reported no remaining Genesis Healthcare, Inc. position as of Q4 2018 after selling out during the quarter.
Cubist Systematic Strategies sold 10,102 Genesis Healthcare, Inc. shares in Q4 2018, an estimated $14K.
Cubist Systematic Strategies first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 12 quarters.
Cubist Systematic Strategies's Genesis Healthcare, Inc. position peaked at $294K in Q1 2015.
75 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2018.

Based on Cubist Systematic Strategies's 13F filing for Q4 2018, filed 14 Feb 2019.